REGISTERED
on 12 Sep 2023
Last Applicant/ Owned by
100 Stieri Court
Mt. Arlington
NJ
07856
Serial Number
97660589 filed on 03rd Nov 2022
Registration Number
7164034 registered on 12th Sep 2023
Correspondent Address
Christine Amara
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
"SYSTEMS"
MEDPRO SYSTEMS
Software as a service (SaaS) services featuring software for use to assist in tracking and reporting healthcare practitioner and healthcare organization interactions and complying with international, federal, state and local spend and transparency laws and regulations; software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies in m Read More
Classification Information
Class [045]
Personal & Legal & Social Services
Regulatory compliance consulting in the field of life sciences, pharmaceuticals, biotechnology, and medical devices; consulting services to assist life sciences, pharmaceutical, biotechnology and medical device companies in the fields of regulatory compliance, namely, compliance in the areas of aggregate spend disclosure reporting, the Prescription Drug Marketing Act, the Drug Supply Chain Security Act, Condition of Participation for Outpatient Services, Stark Law and Ohio Terminal Distributor of Dangerous Drugs requirements; regulatory compliance audits for life sciences, pharmaceutical, biotechnology and medical device companies to assist with regulatory compliance; consulting services in the field of life sciences, pharmaceutical, biotechnology and medical device corporate compliance program and transparency program development, implementation and support; online searchable databases and information concerning historical, current and pending laws, regulations, and guidance documents governing the life sciences industry; regulatory compliance consulting services in the field of aggregate spend disclosure reporting; regulatory and compliance information for pharmaceutical, biotechnology and medical device companies, and for entities involved in the drug and device supply chain, regarding transparency and aggregate spend, marketing, and additional compliance requirements; regulatory compliance consulting, namely, reviewing, developing, training on and assisting with the implementation and monitoring of standards, practices, procedures and policies to support regulatory compliance for companies in the fields of life sciences, pharmaceuticals, biotechnology, and medical devices
First Use Date in General
01st Apr 2021
First Use Date in Commerce
01st Apr 2021
Class [042]
Computer & Software Services & Scientific Services
Software as a service (SaaS) services featuring software for use to assist in tracking and reporting healthcare practitioner and healthcare organization interactions and complying with international, federal, state and local spend and transparency laws and regulations; software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies in managing, validating and enriching healthcare organization and healthcare practitioner data attributes in connection with regulatory compliance, sales and marketing efforts
First Use Date in General
01st Mar 2002
First Use Date in Commerce
01st Mar 2002
Class [041]
Education and Entertainment Services
Consulting services in the nature of conducting trainings for life sciences, pharmaceuticals, biotechnology, and medical device companies personnel and partners on pharmaceutical and medical device compliance program requirements, fraud and corruption laws and regulations, industry codes and best practices; consulting services, namely, developing and providing trainings for life sciences, pharmaceutical, biotechnology, and medical device companies in the field of corporate compliance and transparency programs
First Use Date in General
01st Apr 2021
First Use Date in Commerce
01st Apr 2021
Class [035]
Advertising, Business & Retail Services
Business consulting services for life sciences, pharmaceuticals, biotechnology and medical device companies in the nature of regulatory compliance program development and enhancement and transparency program support, namely, reviewing program status and performing gap analyses, drafting programs plans, program implementation support, development and improvement of policies, standard operating procedures and codes of conduct; business consulting services in the nature of monitoring of pharmaceutical and medical device manufacturer interactions with healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of auditing of pharmaceutical and medical device manufacturer interactions with and payments to healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of business investigation support for internally and externally raised complaints made against a pharmaceutical or medical device manufacturer related to potential violations of their company policy or code, industry code, or law or regulation; transparency reporting regulatory submission management, namely, assisting others in preparing and filing regulatory submissions in the field of transparency reporting for pharmaceutical, biotechnology and medical device companies; business consulting services, namely, tracking and monitoring regulatory requirements for others in the field of life sciences, pharmaceuticals, biotechnology, and medical devices for regulatory compliance; business consulting services, namely, compliance program gap analysis for life sciences, pharmaceutical, biotechnology, and medical device companies
First Use Date in General
01st Apr 2021
First Use Date in Commerce
01st Apr 2021
Mark Details
Serial Number
No 97660589
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Sep 2023 | REGISTERED-PRINCIPAL REGISTER |
| 12th Sep 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 27th Jun 2023 | PUBLISHED FOR OPPOSITION |
| 27th Jun 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 07th Jun 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 22nd May 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 04th Apr 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 04th Apr 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 04th Apr 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 14th Jan 2023 | NON-FINAL ACTION WRITTEN |